BioMark Diagnostics, Inc. (BUX.CX)
0.58
+0.03
(+5.45%)
CAD |
CNSX |
Feb 27, 16:00
BioMark Diagnostics Free Cash Flow : -1.421M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Justera Health Ltd. | -- |
| Neural Therapeutics, Inc. | -- |
| ARCpoint, Inc. | -1.803M |
| Arch Biopartners, Inc. | -1.584M |
| Biocure Technology, Inc. | -0.0773M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.4818M |
| Cash from Investing (Quarterly) | 1.050M |
| Cash from Financing (Quarterly) | -0.0582M |
| Free Cash Flow Per Share (Quarterly) | -0.0047 |
| Free Cash Flow to Equity (Quarterly) | -0.2845M |
| Free Cash Flow to Firm (Quarterly) | -0.4841M |
| Free Cash Flow Yield | -2.41% |